107 related articles for article (PubMed ID: 11837564)
1. Warfarin-associated bleeding complication saved life.
McCall KL; MacLaughlin EJ
Pharmacotherapy; 2002 Feb; 22(2):265-8. PubMed ID: 11837564
[TBL] [Abstract][Full Text] [Related]
2. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
4. Prevention of stroke in patients with atrial fibrillation.
Olsson SB; Halperin JL
Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916
[TBL] [Abstract][Full Text] [Related]
5. The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis.
Gerson LB; Triadafilopoulos G; Gage BF
Am J Med; 2004 Apr; 116(7):451-9. PubMed ID: 15047034
[TBL] [Abstract][Full Text] [Related]
6. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
Moretti LV; Montalvo RO
Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.
Jaakkola S; Nuotio I; Kiviniemi TO; Virtanen R; Virta A; Airaksinen KEJ
Ann Med; 2018 Mar; 50(2):164-171. PubMed ID: 29156997
[TBL] [Abstract][Full Text] [Related]
8. [A Case with the Increased PT-INR after the Addition of Mirtazapine to Warfarin Therapy].
Nishimura H; Kawakami M
Seishin Shinkeigaku Zasshi; 2015; 117(10):820-5. PubMed ID: 26827407
[TBL] [Abstract][Full Text] [Related]
9. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
10. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
11. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
12. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
[TBL] [Abstract][Full Text] [Related]
13. Warfarin therapy for atrial fibrillation in general practice--is bleeding risk underestimated?
Bratland B; Hornnes MB
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):175-9. PubMed ID: 24477151
[TBL] [Abstract][Full Text] [Related]
14. Elevated International Normalized Ratio after concurrent ingestion of cranberry sauce and warfarin.
Mergenhagen KA; Sherman O
Am J Health Syst Pharm; 2008 Nov; 65(22):2113-6. PubMed ID: 18997138
[TBL] [Abstract][Full Text] [Related]
15. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
16. Interaction between gemfibrozil and warfarin: case report and review of the literature.
Dixon DL; Williams VG
Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
[TBL] [Abstract][Full Text] [Related]
17. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
18. Risk of bleeding with dabigatran in atrial fibrillation.
Hernandez I; Baik SH; Piñera A; Zhang Y
JAMA Intern Med; 2015 Jan; 175(1):18-24. PubMed ID: 25365537
[TBL] [Abstract][Full Text] [Related]
19. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
Yasaka M; Minematsu K; Yamaguchi T
Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
[TBL] [Abstract][Full Text] [Related]
20. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
Thomas KS; Billingsley A; Amarshi N; Nair BA
Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
